LAKE FOREST, Ill., Dec. 19, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the J.P. Morgan 33rd Annual Healthcare Conference on Wednesday, Jan. 14, 2015, in San Francisco.
The presentation is scheduled to begin at 10:30 a.m. Pacific time on Wednesday, Jan. 14, 2015. It will be available to all interested parties through a live audiocast accessible via the Investor Relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira website. A replay of the webcast will be available on the Hospira website approximately 24 hours after the live presentation for 30 days after the event.
About Hospira Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 19,000 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.